Detailed answers about AME BLOOD CANCER TRUST, including incorporation, status, business activity, and accounts information.
When was AME BLOOD CANCER TRUST founded?
AME BLOOD CANCER TRUST was officially incorporated on 16 April 2021 and is registered under company number 13339212. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is AME BLOOD CANCER TRUST?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of AME BLOOD CANCER TRUST?
AME BLOOD CANCER TRUST's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does AME BLOOD CANCER TRUST do?
AME BLOOD CANCER TRUST operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is AME BLOOD CANCER TRUST's registered address?
The registered office address of AME BLOOD CANCER TRUST is 23A DUDDEN HILL LANE, LONDON, UNITED KINGDOM, NW10 2ET. This is the official address filed with Companies House for legal and statutory correspondence.
Is AME BLOOD CANCER TRUST financially stable?
The most recent accounts for AME BLOOD CANCER TRUST were made up to 30 April 2025, filed as DORMANT. Next accounts are due by 31 January 2027.